Humacyte Appoints Jim Mercadante as Chief Commercial Officer
Humacyte, Inc. has appointed Jim Mercadante as Chief Commercial Officer to lead its commercial expansion, particularly with the launch of its first FDA-approved product, Symvess, an acellular tissue engineered vessel for vascular trauma. Mercadante brings over 25 years of experience in healthcare and medical technology, with a strong track record in commercial strategy and product launches.
– Industry veteran with more than 25 years of experience will lead next phase of biotech company’s commercial expansion –